{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigmbdjklxlqxpzkube4ffaxqbftwkxpc747fsgad5judpxbhylt3e",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mf7rileqem22"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreierpk7echxkuv7m6rjmsqlpzvxso7t6zjuhzo3fxfpkx2scrg43y4"
    },
    "mimeType": "image/jpeg",
    "size": 78252
  },
  "path": "/news/2026-02-alzheimer-biomarker-rest-protein-attention.html",
  "publishedAt": "2026-02-19T08:52:51.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Neuroscience"
  ],
  "textContent": "Globally, millions of people are affected by Alzheimer's disease, with around 120,000 individuals in Norway alone. Witnessing a loved one gradually decline because of this devastating condition can be heart-wrenching. \"Alzheimer's is a devastating disease, and we still don't have effective ways to stop or reverse it,\" says Beatriz Escobar-Doncel, a Ph.D. student at the Fang-Stavem Lab at the University of Oslo and Akershus University Hospital.",
  "title": "A possible Alzheimer's biomarker? Why REST protein levels are drawing attention"
}